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Xerostomia and pathological thirst are troublesome complications of diabetes mellitus associated with impaired functioning of salivary glands;
however, their cellular mechanisms are not yet determined. Isolated acinar cells were loaded with Ca2+ indicators fura-2/AM for measuring
cytosolic Ca2+ concentration ([Ca2+]i) or mag-fura-2/AM—inside the endoplasmic reticulum (ER). We found a dramatic decrease in pilocarpine-
stimulated saliva flow, protein content and amylase activity in rats after 6 weeks of diabetes vs. healthy animals. This was accompanied with rise
in resting [Ca2+]i and increased potency of acetylcholine (ACh) and carbachol (CCh) but not norepinephrine (NE) to induce [Ca
2+]i transients in
acinar cells from diabetic animals. However, [Ca2+]i transients mediated by Ca
2+ release from ER stores (induced by application of either ACh,
CCh, NE, or ionomycin in Ca2+-free extracellular medium) were decreased under diabetes. Application of inositol-1,4,5-trisphosphate led to
smaller Ca2+ release from ER under the diabetes. Both plasmalemma and ER Ca2+-ATPases activity was reduced and the latter showed the
increased affinity to ATP under the diabetes. We conclude that the diabetes caused impairment of salivary cells functions that, on the cellular level,
associates with Ca2+ overload, increased Ca2+-mobilizing ability of muscarinic but not adrenergic receptors, decreased Ca2+-ATPases activity and
ER Ca2+ content.
© 2005 Elsevier B.V. All rights reserved.Keywords: Salivary gland; Streptozotocin-induced diabetes; Calcium signaling; Ca2(+)-transporting ATPase; Endoplasmic reticulum; Muscarinic receptor;
Adrenergic receptor1. Introduction
Pathological thirst (polydipsia) is one of the troublesome
complications of diabetes mellitus. Xerostomia (oral dryness) is
a common complaint among diabetic patients, which is closely
connected to polydipsia. Xerostomia is associated with damage
to salivary gland activity, resulting in marked decrease in their
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(STZ) on rat salivary glands have been also documented. These
reports suggest that diabetes caused an extensive cellular
degeneration and structural and functional disorders [4–6]. At
the same time, the intracellular mechanisms responsible for
these changes are not yet clear.
The principal regulatory factors controlling the extent and
nature of submandibular salivary gland secretions are auto-
nomic neurotransmitters released by innervating sympathetic
(norepinephrine) and parasympathetic nerves (acetylcholine).
Acetylcholine (ACh) activates M1 and M3 muscarinic receptors,
which are the only ACh-sensitive receptors found in the
membrane of submandibular salivary gland cells [7]. Activation
of both M1 and M3 receptors increases free intracellular Ca
2+
concentration ([Ca2+]i) via production of inositol-1,4,5-
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2+ release by activation
of InsP3 receptors of endoplasmic reticulum (ER). The recent
availability of mutant mice deficient in specific mAChR
subtypes enabled the demonstration of the prominent role of
M3 receptors in cholinergic Ca
2+ signaling, whereas the role of
M1 receptors seems to be minor [8]. Norepinephrine (NE)
activates both α1 and β1 adrenergic receptors present in the
submandibular acinar cells. Similar to muscarinic receptors,
stimulation of α1 adrenergic receptors in adult animals also
leads to increase in InsP3 [9]. However the mechanism of
α-adrenergic activation of ryanodine receptors mediated by
cyclic ADP-ribose was also proposed especially in younger
animals [9].
Regulation of Ca2+ in the cytosol and ER lumen is central to
the regulation of synthesis and secretion of saliva components
[10,11], thus alteration of intracellular Ca2+ handling could be a
basis for impaired salivary gland functioning associated with
diabetes. To the best of our knowledge, there are no reports of
altered [Ca2+]i homeostasis in salivary cells, although this
alteration is currently considered a basic pathology associated
with diabetes complications. Numerous works originating from
different laboratories testify that experimental diabetes leads to
substantial changes in Ca2+ homeostasis in different cell types
[12–16].
The ability of Ca2+ to function efficiently as an
intracellular messenger is due to the existence of effective
metabolic systems that keep [Ca2+]i at a low level in the
cytosol and at a relatively high level in the lumen of the
endoplasmic reticulum (ER). It is also important to note that
the impairment of intrareticular Ca2+([Ca2+]ER) homeostasis
could affect synthesis of secretory proteins, their chaperoning
and maturation [17–19], reviewed in [11]. Regulation of Ca2+
in the cytosol and the ER is achieved by the concerted
activities of several ion channels (some of them coupled to
metabotropic receptors) and Ca2+-ATPases localized in the
endoplasmic reticulum (SERCA) and in the plasma membrane
(PMCA). Numerous reports show that experimental diabetes
alters Ca2+-ATPase activity and expression in other tissues
[20–26] but none pertain to salivary cells.
Thus, knowledge of abnormalities in Ca2+ signaling in the
acinar secretory cells is fundamental to understanding the
etiology of impaired salivation in diabetes. The present study
examined this question.
2. Materials and methods
2.1. Induction of experimental diabetes
Male Wistar rats, 21 postnatal days old, weighting 30±5 g at the beginning
of the experiment were used. They had free access to solid food and water in an
animal room, which was maintained at 25 °C with a 12-h light/dark cycle.
Diabetes was induced by a single intraperitoneal injection of streptozotocin
(STZ, Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) dissolved in 0.9%
NaCl solution using 60 mg/kg proportion; control animals were injected with
saline alone. Animals were used for experiments 6–7 weeks after the onset of
diabetes. All experiments were performed in accordance with regulations
specified by Guide for the Care and Use of Laboratory Animals (1996, National
Academy of Sciences, Washington D.C.) and approved by the Bogomoletz
Institute of Physiology Clinic of Animal Care and Use.2.2. Collection and analysis of saliva from submandibular gland
The rats were anesthetized with i.p. injection of mixture of 100 mg/kg body
weight Ketamine (CuraMed Pharma GmbH, Karlsruhe, Germany) and 0.05 ml/
kg body weight of Lysthenon (Nycomed GmbH, Austria) and then secured in
supine position. Saliva was collected using modification of the cannulation
method. Extra care was taken to prevent contamination of the submandibular
saliva from other types of saliva, for that the opening of the tapered end of a glass
cannula was chosen to resemble the size of submandibular duct papilla, therefore
providing its tight coverage. The other end of the cannula was connected via a
variable speed peristaltic pump to a pre-weighted 1.5 ml centrifuge tube for
collecting the secreted saliva. Pilocarpine (2 mg/kg, i.p.) was used to stimulate
the salivation and saliva was collected for 10 min after the injection. Saliva
protein content was determined using Lowry method, amylase activity by
Caraway method using amylase-test kit (Biotron diagnostics, Hemet, CA, USA).
2.3. Isolation of submandibular salivary gland's acinar cells
Submandibular salivary gland acinar cells were isolated as described
previously [27] using digestion with collagenase P and mechanical
dissociation with Pasteur pipettes. Suspension was filtered through 70 μm
cell strainer to get acini of approximately same size and after that kept in the
Tyrode solution. Tyrode solution contained (in mM): NaCl—135, KCl—5,
HEPES—10, MgCl2—2, CaCl2—2, glucose—10 (pH 7.35). To obtain a Ca
2+-
free solution, CaCl2 was omitted, MgCl2 was increased to 4 mM and 1 mM
EGTAwas added.
2.4. Fluorescence imaging of [Ca2+]i and [Ca
2+]ER
For [Ca2+]i measurements, cells were loaded with Ca
2+ indicator fura-2/AM
(10 μM) for 35 min at 35 °C. Fura-2 ratios were captured at 5 frames per second
as described elsewhere [13], [Ca2+]i values were calculated online using
Grynkiewicz equation [28]. For [Ca2+]ER measurements, mag-fura-2 was loaded
into cells of intact salivary glands by a 45-min incubation with 6 μM mag-fura-
2/AM and 0.02% pluronic F-127 at 37 °C in Tyrode solution. After mounting in
the superfusion chamber, cells were briefly washed with intracellular-like media
(ICM) and permeabilized for 4–8 min with 40 μg ml−1 β-escin in ICM.
Permeabilization was confirmed by monitoring the fall of mag-fura-2
fluorescence (excited at 360 and 390 nm and detected at 510 nm) to less than
20% of its initial intensity. Changes in [Ca2+]ER are expressed as changes in the
ratio of mag-fura-2/AM fluorescence at 360 nm to 390 nm (F360/F390) that are
proportional to [Ca2+]ER. The ICM contained (in mM): KCl, 120; NaCl, 20;
MgSO4, 2; HEPES, 10; ATP, 3; EGTA, 1; CaCl2, 0.75 (pH 7.2).
2.5. Microsomal preparation
All procedures were done at 4 °C using precooled reagents. Immediately
after removal from the body, gland tissue was washed and homogenized at 4 °C
in ice cold solution containing (in mM): sucrose—250, EDTA—1, Tris–HCl—
10 (pH 7.4) using 10–15 strokes of a motor-driven glass-teflon homogenizer.
Homogenate was centrifuged at 1600×g for 10 min to remove nuclear fraction.
Supernatant was then centrifuged at 10,000×g for 10 min to remove pelleted
mitochondria. Resulting supernatant was centrifuged at 100,000×g for 40 min to
yield microsomal pellet. The resulting microsome pellet was resuspended in
homogenization buffer. Microsomes were either used immediately or stored
frozen at −40 °C.
2.6. ATPase assay
A reaction buffer contained (in mM): NaCl—50, KCl—100, Tris–HCl—20,
MgCl2—3, CaCl2—0.01 (pH 7.4; T=37 °C); samples contained 3–5 μg/ml of
protein. The reaction was initiated by the addition of 3 mM ATP at 37 °C and
terminated 1.5 min after initiation by the addition of 20% ice-cold trichloracetic
acid. The time was set to be within the linear range of the reaction. Ca2+-ATPase
activity was measured by colorimetric determination of inorganic phosphate (Pi)
liberated from ATP using a previously described method [29]. To exclude a
possible mitochondrial contaminate, sodium azide (1 mM) was added to the
Table 1
Parameters of salivation in healthy animals and rats with STZ-induced diabetes
Parameter Control Diabetes
Saliva flow rate, ml/kg/h 20.6±1.1 (n=14) 11.7±1.7 (n=10) ⁎
Protein content, mg/ml 4.2±0.6 (n=14) 3.2±0.5 (n=10) ⁎
Amylase activity, mg/sec/l 796±33 (n=9) 118±10 (n=10) ⁎
Values are mean±S.E.M. (number of rats). Statistical analysis was conducted by
means of Student's t test.
⁎ Pb0.01 diabetes vs. control.
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suppress plasma membrane Na+/K+-ATPase activity. The Ca2+-independent
ATPase activity was assayed in the presence of 5 mM EGTA without the
addition of Ca2+. The Ca2+-dependent ATPase activity (Ca2+-ATPase activity)
was obtained by subtracting the Ca2+-independent ATPase activity from the total
activity. To evaluate the activity of SERCA thapsigargin (500 nM) was used.
SERCA activity was calculated from the difference between total Ca2+-ATPase
activity and a thapsigargin-insensitive fraction of Ca2+-ATPase activity (PMCA
activity).
2.7. Data analysis
Ca2+ recording traces were analyzed using Axon imaging workbench
software (Axon Instruments, Union City, CA, USA). Data are expressed as
mean±S.E.M. Equal variance analysis was performed between the control and
STZ group. Statistical significance was calculated using paired and unpaired
two-tailed Student's t-test where appropriate; a P value of less than 0.05 was
considered as statistically significant.3. Results
Fourteen saline-control, 5 STZ-control and 15 diabetic rats
were used in experiments devoted to studying diabetes-induced
changes in Ca2+ signaling mechanisms. Animals for a STZ-
control group were taken into experiments 1–2 days after STZ
injection. We did not observe any difference either in salivation
or in Ca2+ signaling between saline-control and STZ-control
groups, indicating that STZ itself did not affect salivation and
Ca2+ homeostasis in salivary cells. Diabetic rats were taken into
experiments in 6–7 weeks after STZ injection. On average, the
glucose concentration in blood serum was 117±18 mg/dl
(n=14) and 432±90 mg/dl (n=15) for control and diabetic
animals, respectively.
3.1. In vivo studies of submandibular salivary gland
functioning under experimental diabetes
To test the changes in functioning of submandibular salivary
gland under experimental diabetes, we studied the main
parameters of stimulated salivation in healthy and diabetic
rats in vivo. Since the body weight of diabetic animals had a
substantial dispersion (mean 218 g, range 120–250g), we
normalized saliva flow rate (i.e., volume of saliva secreted
during 1 h) to the weight of the animal, as changes in body
weight and submandibular gland weight parallel one another.
Intraperitoneal injection of pilocarpine (a substance for
stimulation of saliva secretion via activation of salivary cells'
muscarinic receptors) increased the salivary flow rate both in
healthy and diabetic animals. Nevertheless, in diabetic animals
the saliva flow rate after pilocarpine stimulation was signifi-
cantly lower (43±8%, Pb0.001, Table 1) than in control rats.
Similar to saliva flow rate, we observed a significant decrease in
saliva protein content of diabetic animals after pilocarpine
stimulation compared to controls ones (24±4%, Pb0.01, Table
1). We have also found a dramatic impairment of saliva amylase
activity in diabetic animals that totaled 85±5% (Pb0.001,
Table 1) as compared to control animals.
Thus, we observed a dramatic decrease in submandibular
gland saliva secretion, total saliva protein content and amylaseactivity under diabetes. Since regulation of both protein
synthesis and secretion is strongly dependent on intracellular
Ca2+, we studied the potential changes in intracellular Ca2+
signaling under experimental diabetes.
3.2. Impairment of Ca2+ homeostasis in salivary cells under
experimental diabetes
3.2.1. Resting [Ca2+]i level
We observed a significant rise in resting [Ca2+]i in cells from
diabetic animals. We found that resting intracellular [Ca2+]i in
acinar cells isolated from control animals was 95±4 nM (n=66)
and 152±3 nM (n=80) in cells from diabetic animals (Fig. 1D).
The rise in resting [Ca2+]i level comprised 60±4% (Pb0.001).
3.2.2. [Ca2+]i transients induced by ACh
We found that the amplitudes of [Ca2+]i transients induced
by bath application of ACh (5 μM) in Ca2+-containing Tyrode
solution were significantly larger in submandibular acinar cells
from diabetic rats (Fig. 1A, B). On average, the amplitudes of
ACh-induced [Ca2+]i transients were 226±15 nM (n=65) and
278±13 nM (n=75) in cells from control and diabetic animals,
respectively. The increase was significant (Pb0.01) and totaled
23±3% (Fig. 1A, B). We found that the time constant (τ) of
the decay phase of ACh-induced [Ca2+]i transients, deter-
mined by single-exponential fits, were significantly prolonged
by 57±11% (Pb0.01) in diabetic animals. On average, the τ
values were 10.8±1.3 (n=40) and 17±1.5 (n=52) s in
salivary cells of control and diabetic animals respectively.
In order to quantify the altered sensitivity of ACh receptors,
we measured the dose–response relationship in cells from
control and diabetic animals. We found that under STZ-induced
diabetes, the dose–response curve of ACh-evoked [Ca2+]i
transients has a significant (Pb0.01) leftward shift and elevated
maximum compared to control (Fig. 1C). Effective concentra-
tion of ACh producing half-maximal response (EC50),
calculated using a Boltzmann fit of experimental points, totaled
0.83±0.06 μM and 0.53±0.05 μM in control and diabetic
conditions respectively.
3.2.3. [Ca2+]i transients induced by NE
NE was also able to elicit [Ca2+]i transients by activation of
α1-adrenoceptors, which is the only adrenoreceptor subtype
known to act through InsP3 pathway. We found that the
amplitudes of [Ca2+]i transients induced by bath application of
NE (10 μM) in Ca2+-containing Tyrode solution were
significantly smaller in submandibular acinar cells from diabetic
Fig. 1. Changes of ACh-induced [Ca2+]i signaling. Original traces of [Ca
2+]i transients induced by 10 s application of ACh in Ca
2+-containing and Ca2+-free
extracellular medium to acinar cells of submandibular glands isolated from control (A) and diabetic (B) animals. The traces shown in A and B are representative of 19
and 21 independent experiments respectively. (C) Normalized dose–response relationships of the amplitude of ACh-induced [Ca2+]i transients against agonist
concentration measured in cells from control and diabetic animals. Both experimental datasets are normalized to maximal [Ca2+]i transient in control conditions and
fitted by Boltzman curve. (D) Average values of resting [Ca2+]i , amplitude of ACh-induced [Ca
2+]i transients in Ca
2+-containing extracellular medium and the ratio of
the ACh-induced [Ca2+]i transients in Ca
2+-free and Ca2+-containing solution in control and diabetic conditions; *Pb0.05 vs. control.
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[Ca2+]i transients were 65±11 nM (n=10) and 42±9 nM (n=8)
in cells from control and diabetic animals respectively. The
decrease was significant (Pb0.01) and totaled 32±5% (Fig. 2C).
3.2.4. Ca2+ release from InsP3-sensitive Ca
2+ store
To study the diabetes-induced changes of inositol-1,4,5-
trisphosphate (InsP3)-sensitive Ca
2+ release from the ER, we
used agonists of mAChRs: ACh and its hydrolysis-resistant
analogue carbamylcholine (CCh). Application of ACh and CCh
was performed in Ca2+ free extracellular medium to exclude
involvement of external Ca2+ influx. Application of ACh (5
μM) in Ca2+-free extracellular solution led to a transient [Ca2+]i
rise with the average amplitude of 158±14 nM (n=19) for
control and 135±11 nM (n=21) for diabetic animals (Fig. 1A,
B). Hence, we observed a significant (14±4%, Pb0.05)
decrease in the amplitude of [Ca2+]i release from the ER upon
activation of mAChRs. The ratio of the amplitude of ACh-induced [Ca2+]i transients in Ca
2+-free media to that in Ca2+
containing solutions was 0.68±0.03 (n=19) for control and
0.49±0.03 (n=21) for diabetic animals (Fig. 1D).
We also found a significant decrease in the amount of
releasable Ca2+ from InsP3-sensitive Ca
2+ stores upon activa-
tion of mAChRs by CCh in salivary cells of diabetic animals.
An application of CCh (5 μM) in Ca2+-free extracellular
solution led to a transient [Ca2+]i rise with the average
amplitude of 142±15 nM (n=18) for control and 96±6 nM
(n=35) for diabetic animals (Fig. 3A, B). This decrease was
significant (Pb0.001) and comprised 32±3%. The dose–
response curve of CCh-evoked [Ca2+]i transients also showed
a significantly (Pb0.01) increased sensitivity (decreased EC50
value) to CCh, while the CCh curve had a significantly (Pb0.01)
decreased slope and maximum value under STZ-induced
diabetes (Fig. 3C). CCh EC50 and slope values were 4.7±0.6
μMand 0.9±0.04 in cells from control animals and 3.0±0.5 μM
and 0.6±0.03 in cells from diabetic rats, respectively.
Fig. 2. Changes of NE-induced [Ca2+]i signaling. Original traces of [Ca
2+]i transients induced by 10 s application of NE in Ca
2+-containing and Ca2+-free extracellular
medium to acinar cells of submandibular glands isolated from control (A) and diabetic (B) animals. Applications of NE were separated by 5-min interval to allow full
recovery after the first transient. Application of ACh was used to test the viability of the cells. The traces shown in A and B are representative of 10 and 8 independent
experiments respectively. (C) Average values of amplitude of NE-induced [Ca2+]i transients in Ca
2+-containing and Ca2+-free extracellular medium in control and
diabetic conditions; *Pb0.05 vs. control.
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and CCh in Ca2+-free extracellular solution, activation of α1-
adrenoceptors with NE also led to significantly decreased Ca2+
release from InsP3-sensitive Ca
2+ stores in acinar cells from
diabetic animals. On average, application of NE (10 μM) in
Ca2+-free extracellular solution led to a transient [Ca2+]i rise
with the amplitude of 37±9 nM (n=10) and 25±8 nM (n=8)
for control and diabetic conditions correspondingly (Fig. 2A, B).
Hence, we observed a significant (33±7%, Pb0.05) decrease in
the amplitude of [Ca2+]i release from the ER upon activation of
α1-adrenoceptors.
3.2.5. Ca2+ release from the ER by ionomycin
To test the changes in the amount of Ca2+ stored within the
ER, we used ionomycin (Ca2+ ionophore that, in the absence of
external Ca2+, releases Ca2+ from the ER in receptor-
independent manner [30]). We found that Ca2+ liberation
from ER stores induced by ionomycin was significantlydecreased in diabetes. On average, amplitudes of ionomycin
(500 nM)-induced Ca2+ release were 95±12 nM (n=10) in
control and 47±7 nM (n=16) in diabetic conditions, a
significant 51±5% decrease (Pb0.01, Fig. 3D).
3.2.6. Ca2+ release from the ER by InsP3
To directly access changes in the amount of Ca2+ released
from the ER upon activation of InsP3 receptors, we loaded cells
with low-affinity Ca2+ indicator—mag-fura-2/AM, which after
plasma membrane permeabilization remains trapped inside the
ER lumen. We found that the application of InsP3 (3 μM) to
permeabilized acinar cells produced transient decrease in the
ratio of F360/F390 that is proportional to the decrease in Ca
2+
concentration inside the ER. The magnitude of the decay in the
F360/F390 ratio was 0.037±0.004 (n=10) and 0.021±0.005
(n=14), in cells from control and diabetic animals respectively
(Fig. 3E). This reduction was significant (Pb0.01) and
comprised 47±10% comparing to control conditions. We also
Fig. 3. Changes in agonists-induced Ca2+ release from the ER. Original traces of [Ca2+]i transients induced by 10 s application of CCh and 40 s application of
ionomycin in Ca2+-free extracellular medium to isolated acinar cells of submandibular glands from control (A) and diabetic (B) animals. (C) The same as Fig. 1C but
for CCh. (D) Average values of [Ca2+]i transients induced by ACh, CCh and ionomycin in Ca
2+-free solution in control and diabetic conditions; *Pb0.05 vs. control.
(E) Changes in F360/F390 ratio of mag-fura-2/AM fluorescence in permeabilized acinar cell in response to the application of InsP3 in control (black line) and diabetic
(grey line) conditions. Changes in F360/F390 ratio are directly proportional to changes in [Ca
2+]ER. Dotted lines are the mono-exponential fits of the ATP-induced
refilling of the ER Ca2+ stores. (F) Average values of InsP3-induced changes of F360/F390 ratio and the time constants of the refilling in control and diabetic conditions;
*Pb0.05 vs. control.
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after the application of InsP3 and subsequent re-addition of ATP
(3 mM), which reflects the rate of the ER Ca2+ store refilling
by SERCA, were significantly prolonged by 129±17.5%
(Pb0.05) in diabetic animals. On average, the τ values were16±2 s (n=10) and 37±5 s (n=14) s in salivary cells of
control and diabetic animals respectively (Fig. 3F).
Thus, we observed that the amplitudes of Ca2+ transients due
to Ca2+ release from the InsP3- and ionomycin-sensitive
intracellular Ca2+ stores of the ER are significantly diminished
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from the cytosol to the extracellular medium may also be
deteriorated under diabetes, considering the increased resting
[Ca2+]i and the substantial prolongation of ACh- and InsP3-
induced Ca2+ signals. These findings may be due to dysfunction
of SERCA and/or PMCA, which are responsible for the
accumulation of Ca2+ in the ER and its extrusion from the
cytosol. To directly test this hypothesis, we assayed the specific
activities of PMCA and SERCA in control and diabetic
conditions.
3.3. Changes in activity and regulation of Ca2+-ATPases under
experimental diabetes
Specific activities of Ca2+-ATPases were measured in tissue
from 28 control and 24 diabetic rats and divided into 7 and 6
samples respectively.
3.3.1. Kinetic parameters of total Ca2+-dependent ATP
hydrolysis
We found significant changes in kinetics of Ca2+-dependent
ATP hydrolysis in salivary cells under STZ-induced diabetes
(Table 2). On average, the maximal amount of inorganic
phosphate (Pi) liberated during Ca
2+-dependent ATP-hydrolysis
in the presence of saturating ATP concentration (Pmax) was
decreased by 52±6% (Pb0.01). The initial activity of the Pi
liberation (V0) was diminished by 50±7% (Pb0.01) under
experimentally-induced diabetes, whereas the time course of
activity (the time needed to liberate the amount of Pi=Pmax/2)
was not significantly different.
3.3.2. ATP dependence of Ca2+-ATPase functioning in control
and STZ-induced diabetes
The ATP dependence of the both PMCA and SERCA was
examined at 0.01–10 mM ATP and [Ca2+]o ∼ 1 μM. Under the
STZ-induced diabetes maximal activities (Vmax) of both Ca
2+-
ATPases appear to be reduced by 47±9% (Pb0.01) for PMCA
and 79±8% (Pb0.01) for SERCA (Fig. 4, Table 2). The Hill
plots of ATP dependence of the Ca2+-ATPase activities inTable 2
Effect of STZ-induced diabetes on kinetics, ATP- and Ca2+-dependence of Ca2+-AT
Parameter Control
Total Ca2+-ATPase
Pmax, μmol/mg 0.82±0.09
V0, μmol/h/mg 0.12±0.005
τ, min 6.8±0.4
PMCA S
Vmax (ATP), μmol/h/mg 7.6±0.7
Km (ATP), mM 0.16±0.05 0
nH (ATP) 1.05±0.2
Vmax (Ca
2+), μmol/h/mg 6.3±0.6
Km (Ca
2+), nM 60±17 1
nH (Ca
2+) 1.0±0.2
Values are mean±S.E.M. Statistical analysis was conducted by means of Student's
⁎ Pb0.01 diabetes vs. control.diabetes exhibited a significant 73±11% (Pb0.01) decrease in
apparent Michaelis constant (Km) for ATP for SERCA and no
significant change for PMCA (Fig. 4, Table 2). The ATP
dependence of PMCA and SERCA exhibited a non-cooperative
profile with nH ∼ 1.0 both in control and diabetic conditions.
3.3.3. Ca2+ dependence of Ca2+-ATPase functions in control
and STZ-induced diabetes
The Ca2+ dependence of the Ca2+-ATPase activities (both
PMCA and SERCA) was examined at [Ca2+]i ≈0.007–300 μM
and 3 mM ATP. The decrease in Vmax under STZ-diabetes was
similar to that observed in the experiments with ATP and totaled
46±7% (Pb0.01) and 70±11% (Pb0.01) for PMCA and
SERCA correspondingly (Table 2). We did not find a significant
difference in Km and Hill coefficient of the Ca
2+ dependence of
PMCA and SERCA molecules between control and diabetic
conditions (Table 2).
4. Discussion
In this study we examined the effects of STZ-induced
diabetes on main parameters of salivation in response to
muscarinic receptor stimulation in the rat submandibular
salivary gland. Since submandibular gland is believed to be
the main source of basal whole saliva, impairment of its
functioning could largely contribute to the development of
xerostomia. The human studies also suggest impairment of
submandibular but not parotid gland in Type II diabetic
patients [1]. We found a marked decrease in saliva flow,
protein content and amylase activity in diabetic animals
under pilocarpine stimulation. This is consistent with the
findings observed at the early stages (2–4 weeks) of STZ-
induced diabetes in rat where prominent decrease in saliva
flow under pilocarpine stimulation was shown [31,32].
However at long terms (6–12 months) of diabetes develop-
ment there is no indication of differences in saliva flow
either from pilocarpine or parasympathetically stimulated
glands [33,34], indicating the availability of some compen-
satory mechanisms. Nevertheless, the cellular mechanismsPases of salivary acinar cells in control and under STZ-induced diabetes
Diabetes
Total Ca2+-ATPase
0.39±0.06 ⁎
0.06±0.007 ⁎
6.8±1.0
ERCA PMCA SERCA
3.1±0.3 4.0±0.4 ⁎ 0.64±0.2 ⁎
.15±0.1 0.12± 0.02 0.04±0.01 ⁎
0.9±0.1 1.1±0.1 0.9±0.1
3.3±0.7 3.4±0.7 ⁎ 1.0±0.4 ⁎
40±50 75±21 160±60
1.0±0.3 1.0±0.1 0.9±0.1
t-test.
Fig. 4. Ca2+-ATPase activity of microsomal fraction of the submandibular salivary gland as a function of ATP concentration at [Ca2+]o ∼1 μM and pH=7.4. ATP-
dependence of Ca2+-ATPases activity (left) and corresponding Hill's plot (right) of PMCA (A) and SERCA (B) in microsomes obtained from control and diabetic
animals. For Km, Vmax and nH values see Table 2.
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well as compensatory changes under diabetes are not clear.
Cytoplasmic and luminal Ca2+ signaling regulate secretion
of saliva components as well as their synthesis [10,18,19] and
could play an important role in the observed changes in
salivation under experimental diabetes. We indeed found
dramatic changes in Ca2+ homeostasis and signaling in acinar
cells of rat submandibular salivary gland after 6–7 weeks of
diabetes development. First, we found elevated resting [Ca2+]i
levels and increased potency of ACh and CCh to induce [Ca2+]i
transients. On the other hand, we observed a reduction in
amplitudes of all [Ca2+]i responses mediated by liberation of
Ca2+ solely from the endoplasmic reticulum store ([Ca2+]i
transients evoked by either ACh, CCh, NE or ionomycin in
Ca2+-free medium). We believe that there is a superimposition
of several mechanisms; first is the increased Ca2+-mobilizing
ability of muscarinic receptors, second is the increased Ca2+
influx across plasma membrane, and third is the diminished
Ca2+ content inside the ER lumen.The assertion of the increased Ca2+-mobilizing ability of
muscarinic receptors under experimental diabetes is supported
by (i) decreased EC50 values for both ACh and CCh; (ii)
potentiation of ACh-induced [Ca2+]i transients. Increased
potency of muscarinic receptors under experimental diabetes
had not previously been shown for submandibular salivary
gland, however, this effect is quite common in other tissues
[35–39] and, as speculated, could be an intrinsic protector
mechanism to the development of autonomic neuropathy
causing a decreased tone of the autonomic nervous system,
which is shown in both rat and human studies [2,40–42].
Nevertheless, the increased amplitude of ACh-induced
[Ca2+]i transients in Ca
2+ containing extracellular solution
cannot be explained only by increased sensitivity of
muscarinic receptors, since mAChR-mediated Ca2+ release
from the ER is reduced. That means an increased Ca2+ influx
across plasma membrane, though the molecular mechanism
has not been explored. It is generally believed that the major
source of transmembrane Ca2+ influx is the Ca2+ release-
302 N.V. Fedirko et al. / Biochimica et Biophysica Acta 1762 (2006) 294–303activated Ca2+ (CRAC) channels [10,43]. There is also evidence
of a store-independent G-protein coupled transmembrane Ca2+
channel [44] in submandibular salivary cells, presumably
transient receptor potential-like protein 6 (TRP6), coupled via
G-protein toM1 andM3 receptors [45].We cannot point out what
particular mechanism is involved in the increased Ca2+ influx
under experimental diabetes, but it is likely that increased
sensitivity of mAChRs can lead to increased activation of G-
protein coupled Ca2+ channels like TRP6.
Magnitudes of NE-induced [Ca2+]i transients were much
smaller that those induced by ACh, which is not surprising
because NE-induced increase in the InsP3 levels is several fold
less than that induced by ACh [9]. On the contrary to ACh, NE-
evoked [Ca2+]i transients in Ca
2+ containing extracellular
solution were decreased during diabetes indicating that
potentiation of Ca2+ responses induced via activation of
muscarinic receptors is not common for other receptor subtypes.
Impairment of Ca2+ signaling induced by NE is consistent with
in vivo experiments, which showed decreased submandibular
salivary flow in response to adrenergic stimulation and reduced
protein concentration in submandibular saliva during sympa-
thetic stimulation [31,33,46].
Despite the potentiation of ACh-induced [Ca2+]i transients in
Ca2+-containing medium, the amplitudes of all ACh-, CCh- and
NE-induced [Ca2+]i transients in Ca
2+-free solution were
decreased under diabetes. Application of InsP3 also induced
smaller release of Ca2+ from the ER indicating that either level of
[Ca2+]ER is lowered or sensitivity of InsP3 receptors is changed
under diabetes. Furthermore, we observed the reduction in
magnitude of Ca2+ release from the ER independently of
activation of InsP3 receptors, i.e., with ionomycin that further
supports the hypothesis of decreased Ca2+ content inside ER
lumen. Interestingly, the reduction in Ca2+ release by ionomycin
was more pronounced than via InsP3 receptors driven by
mAChR activation, further supporting the idea of increased
sensitivity of muscarinic receptors under diabetes.
Along with reduced Ca2+ content of the ER we observed an
increased resting [Ca2+]i and delayed clearance of ACh- and
InsP3-induced Ca
2+ signals. This may reflect altered functioning
of cells' Ca2+-transporting systems like SERCA and PMCA.
Moreover slower replenishment of [Ca2+]ER after the application
of InsP3 clearly indicate deteriorated functioning of SERCA
since in given experimental conditions it is the only system
responsible for the ER refilling. We show, for the first time, that
STZ diabetes dramatically reduces the Ca2+ transporting ability
of both PMCA and SERCA from rat submandibular gland,
which may explain both increased resting [Ca2+]i and dimin-
ished ER Ca2+ content. This could be due to the diminished
number of rotations of the enzyme molecule as a result of
increased lipid peroxidation [25] and/or altered conformational
transitions within E1–E2 model caused by non-enzymatic
glycation of the protein molecule [47]. However, other
mechanisms are likely involved, as non-enzymatic glycation
cannot account for the elevated sensitivity of SERCA molecule
to ATP [47] or explain the more pronounced suppression of
SERCA activity over PMCA. One of the plausible mechanisms
is an increased expression of phospholamban (PLB) underdiabetes [24]], the ancillary inhibitory protein whose detachment
exposes the high-affinity Ca2+ binding sites of SERCA
molecule. However, a recent report suggests that an increase in
PLB may not fully account for the diabetes-induced impairment
of SERCA and introduces a novel mechanism of its posttrans-
lational modification during diabetes [48].
We showed in this report that impairment of salivary cells
functioning under the diabetes is associated with the changes in
Ca2+ signaling. Decreased activities of Ca2+-ATPases and
increased Ca2+ influx appears to be related to increased [Ca2+]i,
a condition referred to as “Ca2+ overload”. Long time Ca2+
overload may lead to Ca2+ accumulation in the mitochondria
followed by ATP depletion and thereby adverse effects on
cellular functioning [49]. Decreased activity of SERCA may
account for the decreased ER Ca2+ refilling that, in turn, leads to
diminished Ca2+ content inside the ER lumen. The latter results
in improper posttranslational processing of ER protein [17],
folding and compromised exit of proteins [18,19] that could
lead to the observed decrease in saliva protein content and
amylase activity.Acknowledgements
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